Clinuvel Pharmaceuticals Limited announced earnings results for the half year ended December 31, 2020. For the half year, the company announced net income was AUD 6.487 million compared to AUD 610,660 a year ago. Basic earnings per share from continuing operations was AUD 0.133 compared to AUD 0.013 a year ago. Diluted earnings per share from continuing operations was AUD 0.127 compared to AUD 0.012 a year ago.